
Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-02-10 08:00:49Desh Rakshak Aushdhalaya Ltd has witnessed a notable shift in its valuation parameters, moving from a risky to an attractive valuation grade despite a recent decline in share price. This recalibration in price-to-earnings and price-to-book value ratios, alongside comparative peer analysis, suggests a potential reappraisal of the stock’s price attractiveness within the Pharmaceuticals & Biotechnology sector.
Read full news article
Desh Rakshak Aushdhalaya Ltd is Rated Strong Sell
2025-12-26 15:13:06Desh Rakshak Aushdhalaya Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 05 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Desh Rakshak Aushdhalaya Faces Mixed Signals Amidst Market and Financial Trends
2025-12-08 08:10:32Desh Rakshak Aushdhalaya, a key player in the Pharmaceuticals & Biotechnology sector, has recently undergone a revision in its market assessment. This shift reflects a complex interplay of technical indicators, valuation metrics, financial trends, and quality parameters, painting a nuanced picture for investors navigating the current landscape.
Read full news article
Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amidst Consecutive Losses
2025-12-05 10:25:32Desh Rakshak Aushdhalaya Ltd, a key player in the Pharmaceuticals & Biotechnology sector, is currently experiencing significant selling pressure, with the stock registering a lower circuit and an absence of buyers. This development comes amid a series of consecutive losses over recent months, signalling distress selling and heightened market caution.
Read full news article
Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amidst Consecutive Losses
2025-12-04 13:41:33Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.86% today and exhibiting a complete absence of buyers. This extreme selling activity signals distress among investors, as the stock continues to underperform both its sector and the broader market benchmarks.
Read full news article
Desh Rakshak Aushdhalaya Sees Unprecedented Buying Interest Amid Upper Circuit Scenario
2025-11-28 15:15:49Desh Rakshak Aushdhalaya Ltd has attracted extraordinary buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting intense demand amid a backdrop of mixed performance metrics over various time frames.
Read full news article
Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses
2025-11-26 10:10:31Desh Rakshak Aushdhalaya Ltd, a key player in the Pharmaceuticals & Biotechnology sector, is currently experiencing severe selling pressure with no buyers in the queue, signalling distress selling and a notable shift in market sentiment. The stock has recorded consecutive declines over the past four days, reflecting a challenging phase for investors amid a broader market context.
Read full news article
Desh Rakshak Aushdhalaya Sees Extraordinary Buying Interest Amid Upper Circuit Scenario
2025-11-26 09:50:35Desh Rakshak Aushdhalaya Ltd has attracted remarkable buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market activity signals a potential multi-day circuit scenario, reflecting strong demand despite recent price volatility.
Read full news article
Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses
2025-11-25 09:40:40Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, registering a sharp decline over the past week with no buyers visible in the order book. The stock’s performance contrasts starkly with broader market trends, signalling distress selling and heightened investor caution.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
13-Jan-2026 | Source : BSEThe Company hereby submit Confirmation Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2025.
Revised Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
12-Jan-2026 | Source : BSEThe Exchange has received the revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ruchika Chaturvedi & Navneet Chaturvedi
Submission Of Revised Disclosure Under Regulation 29(1) Of The Securities And Exchange Board Of India (SEBI) (Substantial Acquisition Of Shares And Takeovers) Regulations 2011
10-Jan-2026 | Source : BSEThe Company hereby submit revised disclosure under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 pursuant to discrepancy observed in the disclosure under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 submitted on September 10 2025
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






